Risk Of Wrongful Medicines Seizures Seen In EU-Central America Trade Deal 06/04/2010 by David Cronin for Intellectual Property Watch 1 Comment A new accord designed to bolster political and economic ties between the European Union and Central America could result in greater seizures of medicines whenever pharmaceutical companies allege that their patents have been infringed, public health advocates have warned.
Public Health Policy In 2010: Research Funding And Regulations 17/03/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment Finding ways to fund research and regulating medication is critical to international public health policy and intellectual property rights specialists in 2010.
Indian Civil Society Raises Concerns Over US Industry-Sponsored IP Summits 11/03/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments Public interest groups in India are raising questions over annual summits involving Indian judges and policymakers that are being funded by major western industry groups, in particular pharmaceutical companies. At this year’s summit, held recently, a section of India’s patent law which prevents the extension of monopoly power for incremental innovations came under attack, the groups have said.
Regards de deux cinéastes africains sur la créativité et le droit d’auteur 10/03/2010 by Cheikh Kane for Intellectual Property Watch 1 Comment Sous l’égide de la Fédération Internationale des Associations de Producteurs de Films (FIAPF), deux cinéastes africains, invités au festival annuel genevois Black Movie, ont tenu à partager leurs idées sur le dynamisme du cinéma africain et la protection du droit d’auteur.
WTO TRIPS Council Considers Workshop On Public Health Amendment 02/03/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments The World Trade Organization group on intellectual property rights met today and ended early, discussing a potential workshop on an amendment intended to ease access to cheaper generic medicines in countries without a pharmaceutical manufacturing sector, a new proposal from Bolivia and three separate longstanding IP issues with no major changes.
Efficacy Of TRIPS Public Health Amendment In Question At WTO 01/03/2010 by Kaitlin Mara for Intellectual Property Watch 4 Comments World Trade Organization members this week will hear a report on an informal meeting on an amendment to intellectual property trade rules intended to allow easier access to medicines, which some argue has had a flawed design from its inception.
Year Ahead: Reforming Global IP Systems – Trends In A2K In 2010 12/02/2010 by Monika Ermert for Intellectual Property Watch 3 Comments Ensuring public access to knowledge while supporting intellectual property rights cuts across broad areas such as internet availability, public health, education and culture, climate change, and basic technical standards. And while the non-profit movement that has worked to encourage access is facing serious challenges this year, they are set to fight it out in the various fora related to essential drugs, books and academic journals, and software again in 2010.
Knowledge Access Blooms In The Desert: Egypt’s Fragile Stake In IP 11/02/2010 by William New, Intellectual Property Watch 7 Comments CAIRO – The launch this week on the new campus of American University in Cairo of a new centre and a new book on access to knowledge in Egypt offered a view on the complexities of the issues and the challenges developing countries face to ensure global intellectual property rights are incorporated into their legal systems in the most locally productive ways possible.
WTO Members To Consider Review Of TRIPS Public Health Amendment 11/02/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment A waiver to World Trade Organization rules intended to aid people in poor countries in gaining access to medicines has remained essentially unused in the over six-and-a-half years since it was put in place. On Friday, member states of the WTO will in an informal meeting discuss this situation and see what, if anything, needs be done.
Accès aux médicaments : création d’un groupe de travail chargé de contrôler les accords de libre échange conclus par l’Union européenne 02/02/2010 by David Cronin for Intellectual Property Watch Leave a Comment BRUXELLES – Les accords de commerce ne doivent pas contenir de clauses relatives aux droits de propriété intellectuelle susceptibles de remettre en cause l’accès des pays pauvres aux médicaments à des prix abordables, a déclaré un député chevronné du Parlement européen.